Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market

Pfizer Inc. (NYSE:PFE) will reportedly no longer sell its hormone replacement therapy Premarin in Canada following an internal review, ending Canadian availability of both its vaginal cream and three oral tablet strengths. Pfizer Canada confirmed to Reuters on Thursday that it…